134 related articles for article (PubMed ID: 23054704)
1. Optimization of soluble human interferon-γ production in Escherichia coli using SUMO fusion partner.
Zhu F; Wang Q; Pu H; Gu S; Luo L; Yin Z
World J Microbiol Biotechnol; 2013 Feb; 29(2):319-25. PubMed ID: 23054704
[TBL] [Abstract][Full Text] [Related]
2. Production of bioactive γ-glutamyl transpeptidase in Escherichia coli using SUMO fusion partner and application of the recombinant enzyme to L-theanine synthesis.
Wang Q; Min C; Zhu F; Xin Y; Zhang S; Luo L; Yin Z
Curr Microbiol; 2011 May; 62(5):1535-41. PubMed ID: 21327888
[TBL] [Abstract][Full Text] [Related]
3. Elastin-like polypeptide fusions for high-level expression and purification of human IFN-γ in Escherichia coli.
Heidari-Japelaghi R; Haddad R; Valizadeh M; Dorani-Uliaie E; Jalali-Javaran M
Anal Biochem; 2019 Nov; 585():113401. PubMed ID: 31442384
[TBL] [Abstract][Full Text] [Related]
4. Expression of soluble and active interferon consensus in SUMO fusion expression system in E. coli.
Peciak K; Tommasi R; Choi JW; Brocchini S; Laurine E
Protein Expr Purif; 2014 Jul; 99():18-26. PubMed ID: 24680730
[TBL] [Abstract][Full Text] [Related]
5. High efficient expression of bioactive human BMP-14 in E. coli using SUMO fusion partner.
Li JF; Cui XW; Ji HY; Qiu T; Ji XM; Du MX; Wu HT; Xu XZ; Zhang SQ
Protein J; 2011 Dec; 30(8):592-7. PubMed ID: 22057545
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of lacticin Q by small ubiquitin-related modifier fusion in Escherichia coli.
Ma Q; Yu Z; Han B; Wang Q; Zhang R
J Microbiol; 2012 Apr; 50(2):326-31. PubMed ID: 22538663
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of rabies virus surface G-protein in Escherichia coli using SUMO fusion.
Singh A; Yadav D; Rai KM; Srivastava M; Verma PC; Singh PK; Tuli R
Protein J; 2012 Jan; 31(1):68-74. PubMed ID: 22134654
[TBL] [Abstract][Full Text] [Related]
8. Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner.
Li JF; Zhang J; Song R; Zhang JX; Shen Y; Zhang SQ
Appl Microbiol Biotechnol; 2009 Aug; 84(2):383-8. PubMed ID: 19582446
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of hepassocin in Escherichia coli using SUMO fusion partner and molecular chaperones.
Wang Q; Zhao J; Wang Y; Sun H; Jiang Y; Luo L; Yin Z
Protein Expr Purif; 2013 Dec; 92(2):135-40. PubMed ID: 24084006
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression and purification of recombinant cotton rat interferon-gamma.
Houard S; Jacquet A; Haumont M; Glineur F; Daminet V; Milican F; Bollen A
Gene; 1999 Nov; 240(1):107-13. PubMed ID: 10564817
[TBL] [Abstract][Full Text] [Related]
11. Fusion to elastin-like polypeptide increases production of bioactive human IFN-γ in tobacco.
Heidari-Japelaghi R; Valizadeh M; Haddad R; Dorani-Uliaie E; Jalali-Javaran M
Transgenic Res; 2020 Aug; 29(4):381-394. PubMed ID: 32686067
[TBL] [Abstract][Full Text] [Related]
12. Soluble expression and purification of the recombinant bioactive peptide precursor BPP-1 in Escherichia coli using a cELP-SUMO dual fusion system.
Rao S; Zang X; Yang Z; Gao L; Yin Y; Fang W
Protein Expr Purif; 2016 Feb; 118():113-9. PubMed ID: 26581779
[TBL] [Abstract][Full Text] [Related]
13. SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23).
Liu X; Chen Y; Wu X; Li H; Jiang C; Tian H; Tang L; Wang D; Yu T; Li X
Appl Microbiol Biotechnol; 2012 Oct; 96(1):103-11. PubMed ID: 22249722
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli.
Uchimura Y; Nakamura M; Sugasawa K; Nakao M; Saitoh H
Anal Biochem; 2004 Aug; 331(1):204-6. PubMed ID: 15246018
[No Abstract] [Full Text] [Related]
15. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology.
Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G
Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523
[TBL] [Abstract][Full Text] [Related]
16. Process development for production of recombinant human interferon-gamma expressed in Escherichia coli.
Khalilzadeh R; Shojaosadati SA; Maghsoudi N; Mohammadian-Mosaabadi J; Mohammadi MR; Bahrami A; Maleksabet N; Nassiri-Khalilli MA; Ebrahimi M; Naderimanesh H
J Ind Microbiol Biotechnol; 2004 Feb; 31(2):63-9. PubMed ID: 14986150
[TBL] [Abstract][Full Text] [Related]
17. High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein.
Zhang X; Xie J; Sun Y; Xu H; Du T; Liu Z; Chen J; Zheng Z; Liu K; Zhang J; Kan M; Li X; Xiao Y
Appl Microbiol Biotechnol; 2014 Jun; 98(12):5499-506. PubMed ID: 24519456
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells.
Lin HY; Thacore HR; Davis PJ; Davis FB
J Clin Endocrinol Metab; 1994 Jul; 79(1):62-5. PubMed ID: 8027254
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for production of an active N-terminally truncated Ulp1 (SUMO protease 1) catalytic domain from Escherichia coli inclusion bodies.
Linova MY; Risør MW; Jørgensen SE; Mansour Z; Kaya J; Sigurdarson JJ; Enghild JJ; Karring H
Protein Expr Purif; 2020 Feb; 166():105507. PubMed ID: 31586598
[TBL] [Abstract][Full Text] [Related]
20. [Cloning, expression and antiviral activity of arctic fox (Alopex lagopus) interferon-gamma gene].
Zhang H; Chai X; Luo G; Wang F; Yi L; Shao X; Yan X
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1625-30. PubMed ID: 19160847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
